Susan Bobulsky - Jan 25, 2024 Form 3 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Commercial Officer, MRD
Signature
/s/ Susan Bobulsky by Stacy L. Taylor, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Jan 25, 2024
Transactions value $
$0
Form type
3
Date filed
3/6/2024, 07:38 PM
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADPT Common Stock 128K Jan 25, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 5K $1.98 Direct F1
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 20K $6.27 Direct F1
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 28.8K $6.55 Direct F1
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 13.5K $28.32 Direct F2
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 20K $39.50 Direct F3
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 22.9K $43.68 Direct F4
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 103K $12.14 Direct F5
holding ADPT Stock Option (Right to Buy) Jan 25, 2024 Common Stock 88.7K $8.46 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are fully exercisable.
F2 The options will vest with respect to 1/4 of such shares on February 27, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options will vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4 The options will vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5 The options will vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F6 The options will vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.